As of 2025-07-06, the Fair Value of Xeris Pharmaceuticals Inc (XERS) is -3.48 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.75 USD, the upside of Xeris Pharmaceuticals Inc is -173.21%.
With the market price of 4.75 USD and our fair value calculation, Xeris Pharmaceuticals Inc (XERS) is not a good investment. Investing in XERS stocks now will result in a potential loss of 173.21%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -91.10 | -122.70 | -94.70 | -62.26 | -54.84 | -85.12 |
| YoY growth | 27.47% | -34.69% | 22.82% | 34.26% | 11.92% | 12.36% |
| Market Cap (mil) | 760.76 |
| P/E | |
| Forward P/E |
| EPS | -0.28 |
| Avg earnings growth rate | 12.36% |
| TTM earnings | -45.08 |